IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
De scrip tion: Re searcher, im porter, ex porter,
pro moter, sales/detailer. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals, bi o -
log i cal prod ucts, bio tech nol ogy prod ucts, oph thal -
mic prod ucts. Es tab lished 1997. 53
phar ma ceu ti cal em ploy ees in 2006. Di vi sions in -
clude: Pharmaceuticals; Re gional Phar ma ceu ti cal
Asia Pa cific Of fice; An i mal Health; Novartis In sti -
tute for Trop i cal Dis eases; Con sumer Health;
Medical Nutrition; Cibavision; Regional Auditing.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 11-20 (2006)
Con tacts (Pharm): Chair man: Linda Seah;
Com mer cial Op er a tions: Tan Siew Siew, Poh
Hwee Tee
Phar ma ceu ti cal Sales: US$ 18-20 mil lion
Prod ucts (% of Sales by Lead ing 5): 55-60%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
SANDIMMUN NEORAL (immunosuppressive
agent)
GLIVEC (antineoplastic other)
ZOMETA (bone cal cium reg u la tor)
DIOVAN (an gio ten sin-II an tag o nist plain)
FEMARA (cytostatic hor mone an tag o nist)
Ther a peu tic Range:
immunosuppressive agents 23%
renin-an gio ten sin sys tem agents 16%
antineoplastics 16%
musculoskeletal drugs other 10%
cytostatic hor mone ther apy 6%
Lead ing Dose Forms:
coated tab lets 40%
cap sules 20%
in fu sions 14%
tab lets 12%
liq uids 5%
SANDOZ
Street Ad dress: 5 Pereira Road No. 04-03,
Asiawide In dus trial Build ing, Sin ga pore 368025
Tel: +65 6 2848189
Fax: +65 6 2802561
Phar ma ceu ti cal Sales: US$ 2-3 mil lion
Prod ucts (% of Sales by Lead ing 5): 90-95%
Ther a peu tic Classes (% of Sales by Lead ing
5): 95-100%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
CURAM (pen i cil lin broad spec trum)
CEFAZOLIN (cephalosporin)
OSPAMOX (pen i cil lin broad spec trum)
PEN I CIL LIN G SOD (pen i cil lin me dium/nar row
spec trum)
LISDENE (ACE in hib i tor plain)
Ther a peu tic Range:
antibacterials sys temic 95%
renin-an gio ten sin sys tem agents 2%
an ti bi ot ics, sulphonamides and antivirals top i cal
2%
an es thet ics 1%
antimycobacterials 1%
Lead ing Dose Forms:
coated tab lets 78%
vi als 12%
cap sules 3%
tab lets 3%
liq uids 2%
SLOVAK REPUBLIC
NOVARTIS CON SUMER HEALTH
Full Name: Novartis Con sumer Health Inc.
Street Ad dress: Trencianska 47, 821 09
Bratislava 2
Tel: +421 2 5542 4931
Fax: +421 2 5556 1386
Phar ma ceu ti cal Sales: US$ 10-12 mil lion
Prod ucts (% of Sales by Lead ing 5): 65-70%
Ther a peu tic Classes (% of Sales by Lead ing
5): 70-75%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
FENISTIL (antipruritic; an ti his ta mine sys temic)
THERAFLU (cold prep a ra tion with out anti-in fec -
tive)
VENORUTON (var i cose ther apy sys temic; var i -
cose ther apy top i cal)
VOLTAREN EMULGEL (antirheumatic top i cal)
OTRIVIN (na sal prep a ra tion top i cal)
Ther a peu tic Range:
cough and cold prep a ra tions 20%
antivaricosis/antihemorrhoidal prep a ra tions
15%
na sal prep a ra tions 15%
anti rheu ma tics top i cal 13%
antipruritics 11%
© 2009 IMS Health In cor po rated or its af fil i ates Page 204